The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® ...

AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment, leveraging its CD123-targeted efficacy per 0114 trial ...

Today, the Government of Canada announced more than $40 million in contributions and low-cost repayable loans to build and repair 149 homes through eight housing projects located in Northern ...

Mattamy Homes, the largest privately owned homebuilder in North America, is pleased to announce the acquisition of 4.1 acres of prime real estate in the established master-planned community of Rocking ...

In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.

The essential thrombocythemia market is on a growth trajectory, driven by increasing diagnosis rates, aging population ...

In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.